Chrysophanol Attenuates Glucocorticoid‐Induced Osteoporosis by Targeting the E74 ‐Like Factor 5/Osteoglycin‐Regulated PI3K / AKT / mTOR Signaling Axis: An In Vitro and In Vivo Study
Phytotherapy Research · 2026
DOI: 10.1002/ptr.70257 ↗At a glance
Journal article in Phytotherapy Research, 2026. Written by Rongjin Chen and 8 co-authors. Institution: Department of Orthopedics, The Second Hospital of Lanzhou University, Lanzhou, China. Major MEDLINE topics: Osteoporosis, Glucocorticoids, Anthraquinones, Intercellular Signaling Peptides and Proteins. 59 references. Funded by: National Natural Science Foundation of China, Lanzhou Science and Technology Plan Program, Natural Science Foundation of Gansu Province.
Abstract (original language)
Glucocorticoid‐induced osteoporosis (GIOP) is the most common form of secondary osteoporosis, characterized by severe impairment of osteoblast function and increased bone fragility. Current therapeutic options inadequately address glucocorticoid (GC)‐induced osteoblast apoptosis and suppress osteogenesis, highlighting the need for novel targeted interventions. To explore the molecular pathogenesis of GIOP and identify therapeutic targets, we performed integrated transcriptomic analysis, bioinformatics approaches, and multiple experimental validation methods. We demonstrate that dexamethasone (DEX), a prototypical GC, robustly upregulates osteoglycin (OGN) expression in both cellular and animal models. Crucially, the transcription factor ELF5 functions as a critical transcriptional repressor of OGN, counteracting DEX effects. ELF5‐mediated OGN repression is essential for maintaining pro‐survival PI3K/AKT/mTOR signaling integrity in osteoblasts. Molecular docking confirmed stable, high‐affinity binding between the natural compound chrysophanol and OGN. Functionally, chrysophanol effectively antagonized DEX‐induced OGN elevation and mitigated osteoblast apoptosis. This work is the first to define a role for the DEX‐OGN‐ELF5 axis in PI3K/AKT/mTOR signaling as critical for osteoblast survival in GIOP. Chrysophanol, as a novel natural compound targeting this OGN‐centric axis, presents a promising and potentially safer therapeutic alternative to bisphosphonates, which are associated with risks like atypical femoral fractures and osteonecrosis of the jaw. Our findings offer novel insights into the molecular pathogenesis of GIOP, identify a potential druggable ELF5/OGN/PI3K/AKT/mTOR signaling axis, and establish a basis for future translational research in GC‐induced bone diseases.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Orthopedics, The Second Hospital of Lanzhou University, Lanzhou, China.
- Orthopedic Clinical Medical Research Center and Intelligent Orthopedic Industry Technology Center of Gansu Province, Lanzhou, China.
- The Second Clinical Medical School, Lanzhou University, Lanzhou, China.
- Department of Orthopedics, Tianshui Hand and Foot Surgery Hospital, Tianshui, China.
ORCID profiles: Rongjin Chen, Chenhui Yang, Yayi Xia
Funding
- National Natural Science Foundation of China
- Lanzhou Science and Technology Plan Program
- Natural Science Foundation of Gansu Province
- Cuiying Scientific and Technological Innovation Program of Lanzhou University Second Hospital
Cite
APA
Chen, R., Yang, C., Chen, C., Yang, F., Xiao, H., Yang, A., Peng, B., Geng, B., & Xia, Y. (2026). Chrysophanol Attenuates Glucocorticoid‐Induced Osteoporosis by Targeting the E74 ‐Like Factor 5/Osteoglycin‐Regulated PI3K / AKT / mTOR Signaling Axis: An In Vitro and In Vivo Study. Phytotherapy Research. https://doi.org/10.1002/ptr.70257
Vancouver
Chen R, Yang C, Chen C, Yang F, Xiao H, Yang A, et al. Chrysophanol Attenuates Glucocorticoid‐Induced Osteoporosis by Targeting the E74 ‐Like Factor 5/Osteoglycin‐Regulated PI3K / AKT / mTOR Signaling Axis: An In Vitro and In Vivo Study. Phytotherapy Research. 2026. doi:10.1002/ptr.70257
BibTeX
@article{Chen2026,
author = {Chen, Rongjin and Yang, Chenhui and Chen, Changshun and Yang, Fei and Xiao, Hefang and Yang, Ao and Peng, Bo and Geng, Bin and Xia, Yayi},
title = {Chrysophanol Attenuates Glucocorticoid‐Induced Osteoporosis by Targeting the E74 ‐Like Factor 5/Osteoglycin‐Regulated PI3K / AKT / mTOR Signaling Axis: An In Vitro and In Vivo Study},
journal = {Phytotherapy Research},
year = {2026},
doi = {10.1002/ptr.70257}
}
EUVIMED